Let's Talk... SMA at Cure SMA 2022

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Jul 05 / Springer Healthcare

Let's Talk... SMA at Cure SMA 2022

Neuroscience Spinal Muscular Atrophy CURE-SMA-2022

Description

In the second part of this episode, Francesco Danilo Tiziano takes a closer look at the impact of newborn screening for spinal muscular atrophy on patient outcomes and clinical practice.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.